Related Experiment Videos
Amplification of MDM2 inhibits MyoD-mediated myogenesis
T A Fiddler1, L Smith, S J Tapscott
1Department of Molecular and Medical Genetics, Oregon Health Sciences University, Portland 97201, USA.
Abstract:
One obvious phenotype of tumor cells is the lack of terminal differentiation. We previously classified rhabdomyosarcoma cell lines as having either a recessive or a dominant nondifferentiating phenotype. To study the genetic basis of the dominant nondifferentiating phenotype, we utilized microcell fusion to transfer chromosomes from rhabdomyosarcoma cells into C2C12 myoblasts. Transfer of a derivative chromosome 14 inhibits differentiation. The derivative chromosome 14 contains a DNA amplification. MDM2 is amplified and overexpressed in these nondifferentiating hybrids and in the parental rhabdomyosarcoma. Forced expression of MDM2 inhibits MyoD-dependent transcription. Expression of antisense MDM2 restores MyoD-dependent transcriptional activity. We conclude that amplification and overexpression of MDM2 inhibit MyoD function, resulting in a dominant nondifferentiating phenotype.
Insights
Amplification of MDM2 in tumor cells prevents differentiation. This study shows MDM2 overexpression inhibits MyoD function, leading to a dominant nondifferentiating phenotype in rhabdomyosarcoma.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Biology
Background:
- Tumor cells often exhibit a lack of terminal differentiation, a key characteristic.
- Rhabdomyosarcoma cell lines were previously categorized by their nondifferentiating phenotype (recessive or dominant).
Purpose of the Study:
- To investigate the genetic underpinnings of the dominant nondifferentiating phenotype in rhabdomyosarcoma.
- To identify specific genetic factors responsible for inhibiting cellular differentiation.
Main Methods:
- Utilized microcell fusion to introduce chromosomes from rhabdomyosarcoma cells into C2C12 myoblasts.
- Analyzed DNA amplification and gene expression, specifically focusing on MDM2.
- Assessed the impact of MDM2 on MyoD-dependent transcription.
Main Results:
- Transfer of a derivative chromosome 14 into C2C12 myoblasts inhibited differentiation.
- MDM2 was found to be amplified and overexpressed in nondifferentiating hybrids and parental rhabdomyosarcoma cells.
- Forced MDM2 expression suppressed MyoD-dependent transcription, while antisense MDM2 restored it.
Conclusions:
- Amplification and overexpression of MDM2 are key drivers of the dominant nondifferentiating phenotype.
- MDM2 directly inhibits the function of MyoD, a critical transcription factor for muscle differentiation.
- Understanding MDM2's role provides insight into rhabdomyosarcoma development and potential therapeutic targets.